These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8380878)

  • 1. Morphine induced analgesia is attenuated in post-partum lactating rats.
    Janik J; Callahan P; Rabii J
    Life Sci; 1993; 52(3):271-9. PubMed ID: 8380878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.
    Bodnar RJ; Williams CL; Lee SJ; Pasternak GW
    Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced straub tail response: mediated by central mu2-opioid receptor.
    Nath C; Gupta MB; Patnaik GK; Dhawan KN
    Eur J Pharmacol; 1994 Sep; 263(1-2):203-5. PubMed ID: 7821354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxonazine actions in vivo.
    Ling GS; Simantov R; Clark JA; Pasternak GW
    Eur J Pharmacol; 1986 Sep; 129(1-2):33-8. PubMed ID: 3021478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K; Kourides IA; Pasternak GW
    Life Sci; 1982 Nov 15-22; 31(20-21):2177-80. PubMed ID: 6298516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical analgesia produced by low doses of the opiate-antagonist naloxone is mediated by interaction at a site with characteristics of the delta opioid receptor.
    Taiwo YO; Basbaum AI; Perry F; Levine JD
    J Pharmacol Exp Ther; 1989 Apr; 249(1):97-100. PubMed ID: 2540325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus.
    Byrnes EM
    Brain Res; 2008 Jan; 1190():186-92. PubMed ID: 18083149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H; Poulos CX; Lê AD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):425-7. PubMed ID: 2560204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine.
    Wood PL; Pasternak GW
    Neurosci Lett; 1983 Jun; 37(3):291-3. PubMed ID: 6310456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-tolerance between analgesic low doses of morphine and naloxone in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1987 Mar; 405(1):123-9. PubMed ID: 3032345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of morphine analgesia from physical dependence.
    Ling GS; MacLeod JM; Lee S; Lockhart SH; Pasternak GW
    Science; 1984 Oct; 226(4673):462-4. PubMed ID: 6541807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventromedial and medial preoptic hypothalamic ibotenic acid lesions potentiate systemic morphine analgesia in female, but not male rats.
    Cataldo G; Lovric J; Chen CC; Pytte CL; Bodnar RJ
    Behav Brain Res; 2010 Dec; 214(2):301-16. PubMed ID: 20678986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat.
    Dickenson AH; Oliveras JL; Besson JM
    Brain Res; 1979 Jul; 170(1):95-111. PubMed ID: 223722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. μ-Opioid and N-methyl-D-aspartate receptors in the amygdala contribute to minocycline-induced potentiation of morphine analgesia in rats.
    Ghazvini H; Rezayof A; Ghasemzadeh Z; Zarrindast MR
    Behav Pharmacol; 2015 Jun; 26(4):383-92. PubMed ID: 25563202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.